Electrification in life sciences is emerging as a strategic imperative beyond mere carbon reduction. New research reveals it ...

Wave Life Sciences has lost nearly 70% of its value this year, and its RNA platform could make it irresistible to the right ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. In a move that will grow its ...

Over the last six months, Gilead Sciences’s shares have sunk to $137.77, producing a disappointing 11.3% loss - a stark ...

Wave Life Sciences (WVE) stock analysis: low valuation (2.45x cash, no debt) vs. RNA therapy competition; key upside tied to WVE-N531 results. See more here.

Carelon Research, a subsidiary of Elevance Health, and Manifold, an enterprise agent platform for life sciences, today announced a strategic partnership that gives life sciences researchers and data ...

Life sciences organisations generate data at extraordinary speed, but insight remains slow. Semantic knowledge graphs and ontologies address this by providing context and structur ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Greetings. Welcome to the CV Sciences, Inc. Q2 2026 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to Brendan Hawkins. Thank ...

The U.S. life sciences industry is showing early signs of a sustained recovery, providing a potential catalyst for one of commercial real estate's most challenged sectors as renewed hiring and venture ...